Genome-wide genotyping in Parkinson's disease and neurologically normal controls: first stage analysis and public release of data
Top Cited Papers
- 1 November 2006
- journal article
- research article
- Published by Elsevier in The Lancet Neurology
- Vol. 5 (11) , 911-916
- https://doi.org/10.1016/s1474-4422(06)70578-6
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Lack of replication of thirteen single-nucleotide polymorphisms implicated in Parkinson's disease: a large-scale international studyThe Lancet Neurology, 2006
- Genomewide Association, Parkinson Disease, and PARK10American Journal of Human Genetics, 2006
- Conflicting Results Regarding the Semaphorin Gene (SEMA5A) and the Risk for Parkinson DiseaseAmerican Journal of Human Genetics, 2006
- No Evidence for Association with Parkinson Disease for 13 Single-Nucleotide Polymorphisms Identified by Whole-Genome Association ScreeningAmerican Journal of Human Genetics, 2006
- A Case-Control Association Study of the 12 Single-Nucleotide Polymorphisms Implicated in Parkinson Disease by a Recent Genome ScanAmerican Journal of Human Genetics, 2006
- Joint analysis is more efficient than replication-based analysis for two-stage genome-wide association studiesNature Genetics, 2006
- A haplotype map of the human genomeNature, 2005
- Complement Factor H Polymorphism in Age-Related Macular DegenerationScience, 2005
- The International HapMap ProjectNature, 2003
- Mutation in the α-Synuclein Gene Identified in Families with Parkinson's DiseaseScience, 1997